Vulnerability in Hospira Symbiq Infusion System
CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS 0.029, 87.1th percentile (scored ); unchanged over 30 days. About EPSS.
Affected products
- Hospira Symbiq Infusion System — versions 3.13 and earlier
- Pfizer Symbiq Infusion System Firmware
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSA-15-174-01 (US Government Resource, Third Party Advisory)